 | • レポートコード：QYR2104Z4576 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、薬物動態のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非コンパートメント方式、コンパートメント方式）、用途別市場規模（腫瘍、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・薬物動態の市場動向 ・企業の競争状況、市場シェア ・薬物動態の種類別市場規模（非コンパートメント方式、コンパートメント方式） ・薬物動態の用途別市場規模（腫瘍、心血管疾患、感染症、自己免疫疾患、呼吸器疾患、神経疾患、その他） ・薬物動態の北米市場規模2016-2027（アメリカ、カナダ） ・薬物動態のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・薬物動態のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・薬物動態の中南米市場規模2016-2027（メキシコ、ブラジル） ・薬物動態の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Charles River Laboratories、Covance、Cyprotex、Drumetix Laboratories、Eurofins Scientific、GVK Biosciences、LGC、Parexel、Pharmoptima、TCG Lifesciences） ・結論 |
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
Pharmacokinetics describes how the body affects a specific chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic changes of the substance in the body, and the effects and routes of excretion of the metabolites of the drug.
Market Analysis and Insights: Global Pharmacokinetics Market
The global Pharmacokinetics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacokinetics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacokinetics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacokinetics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacokinetics market.
Global Pharmacokinetics Scope and Market Size
Pharmacokinetics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacokinetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Noncompartmental Methods
Compartmental Methods
Segment by Application
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Noncompartmental Methods
1.2.3 Compartmental Methods
1.3 Market by Application
1.3.1 Global Pharmacokinetics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Infectious Diseases
1.3.5 Autoimmune Diseases
1.3.6 Respiratory Disorders
1.3.7 Neurological Disorders
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Market Perspective (2016-2027)
2.2 Pharmacokinetics Growth Trends by Regions
2.2.1 Pharmacokinetics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmacokinetics Historic Market Share by Regions (2016-2021)
2.2.3 Pharmacokinetics Forecasted Market Size by Regions (2022-2027)
2.3 Pharmacokinetics Industry Dynamic
2.3.1 Pharmacokinetics Market Trends
2.3.2 Pharmacokinetics Market Drivers
2.3.3 Pharmacokinetics Market Challenges
2.3.4 Pharmacokinetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Players by Revenue
3.1.1 Global Top Pharmacokinetics Players by Revenue (2016-2021)
3.1.2 Global Pharmacokinetics Revenue Market Share by Players (2016-2021)
3.2 Global Pharmacokinetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Revenue
3.4 Global Pharmacokinetics Market Concentration Ratio
3.4.1 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Revenue in 2020
3.5 Pharmacokinetics Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Breakdown Data by Type
4.1 Global Pharmacokinetics Historic Market Size by Type (2016-2021)
4.2 Global Pharmacokinetics Forecasted Market Size by Type (2022-2027)
5 Pharmacokinetics Breakdown Data by Application
5.1 Global Pharmacokinetics Historic Market Size by Application (2016-2021)
5.2 Global Pharmacokinetics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmacokinetics Market Size (2016-2027)
6.2 North America Pharmacokinetics Market Size by Type
6.2.1 North America Pharmacokinetics Market Size by Type (2016-2021)
6.2.2 North America Pharmacokinetics Market Size by Type (2022-2027)
6.2.3 North America Pharmacokinetics Market Size by Type (2016-2027)
6.3 North America Pharmacokinetics Market Size by Application
6.3.1 North America Pharmacokinetics Market Size by Application (2016-2021)
6.3.2 North America Pharmacokinetics Market Size by Application (2022-2027)
6.3.3 North America Pharmacokinetics Market Size by Application (2016-2027)
6.4 North America Pharmacokinetics Market Size by Country
6.4.1 North America Pharmacokinetics Market Size by Country (2016-2021)
6.4.2 North America Pharmacokinetics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pharmacokinetics Market Size (2016-2027)
7.2 Europe Pharmacokinetics Market Size by Type
7.2.1 Europe Pharmacokinetics Market Size by Type (2016-2021)
7.2.2 Europe Pharmacokinetics Market Size by Type (2022-2027)
7.2.3 Europe Pharmacokinetics Market Size by Type (2016-2027)
7.3 Europe Pharmacokinetics Market Size by Application
7.3.1 Europe Pharmacokinetics Market Size by Application (2016-2021)
7.3.2 Europe Pharmacokinetics Market Size by Application (2022-2027)
7.3.3 Europe Pharmacokinetics Market Size by Application (2016-2027)
7.4 Europe Pharmacokinetics Market Size by Country
7.4.1 Europe Pharmacokinetics Market Size by Country (2016-2021)
7.4.2 Europe Pharmacokinetics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Market Size (2016-2027)
8.2 Asia-Pacific Pharmacokinetics Market Size by Type
8.2.1 Asia-Pacific Pharmacokinetics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmacokinetics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmacokinetics Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmacokinetics Market Size by Application
8.3.1 Asia-Pacific Pharmacokinetics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmacokinetics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmacokinetics Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmacokinetics Market Size by Region
8.4.1 Asia-Pacific Pharmacokinetics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmacokinetics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Market Size (2016-2027)
9.2 Latin America Pharmacokinetics Market Size by Type
9.2.1 Latin America Pharmacokinetics Market Size by Type (2016-2021)
9.2.2 Latin America Pharmacokinetics Market Size by Type (2022-2027)
9.2.3 Latin America Pharmacokinetics Market Size by Type (2016-2027)
9.3 Latin America Pharmacokinetics Market Size by Application
9.3.1 Latin America Pharmacokinetics Market Size by Application (2016-2021)
9.3.2 Latin America Pharmacokinetics Market Size by Application (2022-2027)
9.3.3 Latin America Pharmacokinetics Market Size by Application (2016-2027)
9.4 Latin America Pharmacokinetics Market Size by Country
9.4.1 Latin America Pharmacokinetics Market Size by Country (2016-2021)
9.4.2 Latin America Pharmacokinetics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Market Size (2016-2027)
10.2 Middle East & Africa Pharmacokinetics Market Size by Type
10.2.1 Middle East & Africa Pharmacokinetics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmacokinetics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmacokinetics Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmacokinetics Market Size by Application
10.3.1 Middle East & Africa Pharmacokinetics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmacokinetics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmacokinetics Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmacokinetics Market Size by Country
10.4.1 Middle East & Africa Pharmacokinetics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmacokinetics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Pharmacokinetics Introduction
11.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2016-2021)
11.1.5 Charles River Laboratories Recent Development
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance Pharmacokinetics Introduction
11.2.4 Covance Revenue in Pharmacokinetics Business (2016-2021)
11.2.5 Covance Recent Development
11.3 Cyprotex
11.3.1 Cyprotex Company Details
11.3.2 Cyprotex Business Overview
11.3.3 Cyprotex Pharmacokinetics Introduction
11.3.4 Cyprotex Revenue in Pharmacokinetics Business (2016-2021)
11.3.5 Cyprotex Recent Development
11.4 Drumetix Laboratories
11.4.1 Drumetix Laboratories Company Details
11.4.2 Drumetix Laboratories Business Overview
11.4.3 Drumetix Laboratories Pharmacokinetics Introduction
11.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2016-2021)
11.4.5 Drumetix Laboratories Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Pharmacokinetics Introduction
11.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2016-2021)
11.5.5 Eurofins Scientific Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Details
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Pharmacokinetics Introduction
11.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2016-2021)
11.6.5 GVK Biosciences Recent Development
11.7 LGC
11.7.1 LGC Company Details
11.7.2 LGC Business Overview
11.7.3 LGC Pharmacokinetics Introduction
11.7.4 LGC Revenue in Pharmacokinetics Business (2016-2021)
11.7.5 LGC Recent Development
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Pharmacokinetics Introduction
11.8.4 Parexel Revenue in Pharmacokinetics Business (2016-2021)
11.8.5 Parexel Recent Development
11.9 Pharmoptima
11.9.1 Pharmoptima Company Details
11.9.2 Pharmoptima Business Overview
11.9.3 Pharmoptima Pharmacokinetics Introduction
11.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2016-2021)
11.9.5 Pharmoptima Recent Development
11.10 TCG Lifesciences
11.10.1 TCG Lifesciences Company Details
11.10.2 TCG Lifesciences Business Overview
11.10.3 TCG Lifesciences Pharmacokinetics Introduction
11.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2016-2021)
11.10.5 TCG Lifesciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmacokinetics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Noncompartmental Methods
Table 3. Key Players of Compartmental Methods
Table 4. Global Pharmacokinetics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharmacokinetics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmacokinetics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharmacokinetics Market Share by Regions (2016-2021)
Table 8. Global Pharmacokinetics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharmacokinetics Market Share by Regions (2022-2027)
Table 10. Pharmacokinetics Market Trends
Table 11. Pharmacokinetics Market Drivers
Table 12. Pharmacokinetics Market Challenges
Table 13. Pharmacokinetics Market Restraints
Table 14. Global Pharmacokinetics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharmacokinetics Market Share by Players (2016-2021)
Table 16. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics as of 2020)
Table 17. Ranking of Global Top Pharmacokinetics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharmacokinetics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacokinetics Product Solution and Service
Table 21. Date of Enter into Pharmacokinetics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharmacokinetics Revenue Market Share by Type (2016-2021)
Table 25. Global Pharmacokinetics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharmacokinetics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharmacokinetics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharmacokinetics Revenue Market Share by Application (2016-2021)
Table 29. Global Pharmacokinetics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharmacokinetics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmacokinetics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharmacokinetics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharmacokinetics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharmacokinetics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmacokinetics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmacokinetics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmacokinetics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharmacokinetics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Charles River Laboratories Company Details
Table 62. Charles River Laboratories Business Overview
Table 63. Charles River Laboratories Pharmacokinetics Product
Table 64. Charles River Laboratories Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 65. Charles River Laboratories Recent Development
Table 66. Covance Company Details
Table 67. Covance Business Overview
Table 68. Covance Pharmacokinetics Product
Table 69. Covance Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 70. Covance Recent Development
Table 71. Cyprotex Company Details
Table 72. Cyprotex Business Overview
Table 73. Cyprotex Pharmacokinetics Product
Table 74. Cyprotex Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 75. Cyprotex Recent Development
Table 76. Drumetix Laboratories Company Details
Table 77. Drumetix Laboratories Business Overview
Table 78. Drumetix Laboratories Pharmacokinetics Product
Table 79. Drumetix Laboratories Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 80. Drumetix Laboratories Recent Development
Table 81. Eurofins Scientific Company Details
Table 82. Eurofins Scientific Business Overview
Table 83. Eurofins Scientific Pharmacokinetics Product
Table 84. Eurofins Scientific Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 85. Eurofins Scientific Recent Development
Table 86. GVK Biosciences Company Details
Table 87. GVK Biosciences Business Overview
Table 88. GVK Biosciences Pharmacokinetics Product
Table 89. GVK Biosciences Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 90. GVK Biosciences Recent Development
Table 91. LGC Company Details
Table 92. LGC Business Overview
Table 93. LGC Pharmacokinetics Product
Table 94. LGC Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 95. LGC Recent Development
Table 96. Parexel Company Details
Table 97. Parexel Business Overview
Table 98. Parexel Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 99. Parexel Recent Development
Table 100. Pharmoptima Company Details
Table 101. Pharmoptima Business Overview
Table 102. Pharmoptima Pharmacokinetics Product
Table 103. Pharmoptima Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 104. Pharmoptima Recent Development
Table 105. TCG Lifesciences Company Details
Table 106. TCG Lifesciences Business Overview
Table 107. TCG Lifesciences Pharmacokinetics Product
Table 108. TCG Lifesciences Revenue in Pharmacokinetics Business (2016-2021) & (US$ Million)
Table 109. TCG Lifesciences Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacokinetics Market Share by Type: 2020 VS 2027
Figure 2. Noncompartmental Methods Features
Figure 3. Compartmental Methods Features
Figure 4. Global Pharmacokinetics Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Diseases Case Studies
Figure 7. Infectious Diseases Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Respiratory Disorders Case Studies
Figure 10. Neurological Disorders Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmacokinetics Report Years Considered
Figure 13. Global Pharmacokinetics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Pharmacokinetics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pharmacokinetics Market Share by Regions: 2020 VS 2027
Figure 16. Global Pharmacokinetics Market Share by Regions (2022-2027)
Figure 17. Global Pharmacokinetics Market Share by Players in 2020
Figure 18. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacokinetics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Pharmacokinetics Revenue in 2020
Figure 20. Global Pharmacokinetics Revenue Market Share by Type (2016-2021)
Figure 21. Global Pharmacokinetics Revenue Market Share by Type (2022-2027)
Figure 22. North America Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Pharmacokinetics Market Share by Type (2016-2027)
Figure 24. North America Pharmacokinetics Market Share by Application (2016-2027)
Figure 25. North America Pharmacokinetics Market Share by Country (2016-2027)
Figure 26. United States Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pharmacokinetics Market Share by Type (2016-2027)
Figure 30. Europe Pharmacokinetics Market Share by Application (2016-2027)
Figure 31. Europe Pharmacokinetics Market Share by Country (2016-2027)
Figure 32. Germany Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pharmacokinetics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Pharmacokinetics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Pharmacokinetics Market Share by Region (2016-2027)
Figure 42. China Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pharmacokinetics Market Share by Type (2016-2027)
Figure 50. Latin America Pharmacokinetics Market Share by Application (2016-2027)
Figure 51. Latin America Pharmacokinetics Market Share by Country (2016-2027)
Figure 52. Mexico Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pharmacokinetics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Pharmacokinetics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Pharmacokinetics Market Share by Country (2016-2027)
Figure 58. Turkey Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Pharmacokinetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Charles River Laboratories Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 62. Covance Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 63. Cyprotex Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 64. Drumetix Laboratories Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 65. Eurofins Scientific Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 66. GVK Biosciences Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 67. LGC Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 68. Parexel Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 69. Pharmoptima Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 70. TCG Lifesciences Revenue Growth Rate in Pharmacokinetics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の動物用自己免疫疾患検査市場規模・現状・予測（2021年-2027年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…- 世界の動物用自己免疫疾患検査市場規模・現状・予測（2021年-2027年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
- 世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Graves' disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on i…
- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Diseases Treatment Market The global Autoimmune Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…